Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shenyang Dongxin Pharmaceutical is a Chinese pharmaceutical company based in Shenyang, Liaoning Province, specializing in the research, development, and manufacturing of both Traditional Chinese Medicine (TCM) and chemical pharmaceuticals. The company's product portfolio includes a variety of dosage forms such as capsules, tablets, and granules, with a particular focus on cardiovascular and cerebrovascular health. Key products include Xinnao Shuantong Capsules, which are used for treating conditions related to blood circulation and stroke recovery. Shenyang Dongxin operates modern manufacturing facilities that comply with Good Manufacturing Practice (GMP) standards to supply the domestic Chinese market. The company is recognized as a high-tech enterprise within its region and maintains a significant presence in the provincial healthcare industry.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Shenyang Dongxin Pharmaceutical.